Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      New Research Adds Support to Change Heartworm Protocol

      Phase 2 Study calls for fighting both the mosquito and the heartworm

      A new research study suggests a Double Defense protocol may protect your pet best from heartworms. Learn more at www.fightheartwormsnow.com

      News provided by

      Ceva Animal Health

      Aug 05, 2016, 05:13 ET

      Share this article

      Share this article


      SAN ANTONIO, Aug. 5, 2016 /PRNewswire/ -- AVMA Convention -- Phase 2 of a groundbreaking study by John McCall, MS, PhD, demonstrates an even greater need to change the approach in fighting the rising incidence of heartworm infection in #dogs. The new data shows that blocking transmission from dogs to mosquitoes, and from mosquitoes to dogs, using repellents/insecticides and macrocyclic lactone preventives is part of a multi-modal approach. The data will be discussed at a press conference briefing Saturday August 6, presented as a poster session on Sunday August 7 at the American Association of Veterinary Parasitologists Annual Meeting and as an educational session at the AVMA on Monday August 8. #FightHeartworm #veterinary

      A mosquito bite is more than just an ouch! That bite transmits diseases - possibly Zika to people and heartworms to our beloved pets. There are ways to reduce the mosquito population around your home, prevent bites and protect the whole family. And, a new study suggests a "Double Defense" protocol may protect your pet best. Learn more at www.fightheartwormnow.com
      A mosquito bite is more than just an ouch! That bite transmits diseases - possibly Zika to people and heartworms to our beloved pets. There are ways to reduce the mosquito population around your home, prevent bites and protect the whole family. And, a new study suggests a "Double Defense" protocol may protect your pet best. Learn more at www.fightheartwormnow.com

      Phase 1 of McCall's research showed the value of topical repellent insecticidal products in a "double defense" protocol for protecting dogs against the vector – the mosquito and use of a preventive against heartworm disease. The study was presented at the Western Veterinary Conference in March 2016. Phase 2 of McCall's study further supports using a topical parasiticide to repel and kill mosquitoes, rather than relying solely on an oral heartworm preventive. These two studies combined send a powerful message regarding the efficacy of a double defense protocol.

      "This second phase of the Ceva sponsored investigation uncovers an important benefit of the mosquito repellency feature of Vectra® 3D," says Elizabeth Hodgkins, Veterinary Relations Director for Ceva Animal Health. "This research shows that Vectra® 3D, by repelling and killing mosquitoes that may transmit the disease, adds an extra layer of protection along with the heartworm preventive.  This is exciting news, and reinforces the new "Double Defense" protocol – Vectra® 3D and a heartworm preventive - for protecting dogs from mosquitoes and heartworm disease transmission."

      McCall's Phase 2 findings included:

      • The overall anti-feeding efficacy of Vectra 3D was 98.5 percent.
      • No worms were found in the Vectra 3D and heartworm preventive treated group.
      • The combination of Vectra 3D for mosquito control and a heartworm preventive had superior efficacy for protecting dogs against heartworm infection compared to a heartworm preventive alone in Phase 2 of the study.

      John McCall is a professor emeritus in the Department of Infectious Diseases at the University of Georgia College of Veterinary Medicine. His work in the Phase 2 study proves that Vectra® 3D, a topical parasiticide, plays a leading role in the double defense protocol by repelling and killing mosquitoes. (See the full details on the design and results of the new study at FightHeartwormNow.com.)

      "This is a new area to explore in veterinary medicine, and I am very excited about the results. After fighting heartworm the same way for decades, it's time for a new approach," McCall says, "and that includes fighting the mosquito as well as the heartworm."

      This new protocol comes as the incidence of heartworm disease continues to increase nationally. In just two years, from 2013-2015, there was a 166 percent increase in reported positive heartworm cases, according to the Companion Animal Parasite Council (CAPC). Additionally, the American Heartworm Society (AHS) has tracked the geographic spread of heartworm disease to all 50 states and its increased prevalence in several regions of the country.

      "The AHS stresses the importance to pet owners of giving a heartworm preventive year-round to prevent the serious and often deadly consequences of heartworm disease," says Tom Nelson, AHS executive board member and co-author of the society's guidelines for the prevention, diagnosis and management of heartworm infection. "The multimodal approach, like on the human side, is something we need to embrace more in veterinary medicine and we need to look at how we can decrease the exposure to the infection."

      For the past several years, most veterinarians relied on a unimodal strategy to protect dogs by prescribing oral medications, but vector control has received little attention.

      "We've really neglected the other parasite that's involved in the heartworm life cycle, and that's the mosquito," says Susan Little, DVM, PhD, and Regents Professor of Parasitology at Oklahoma State University. "Now we can implement a double defense approach and actually use something that repels and kills mosquitoes, in addition to the heartworm preventive."

      Ceva Animal Health will continue its extensive campaign to educate the veterinarian community on the groundbreaking research. A shareable infographic showcasing the dangers of mosquitoes and how the Double Defense Protocol can help protect your dog can be found here. #FightHeartworm #veterinary

      About Ceva Animal Health, LLC: Ceva's key companion animal products include the Vectra® line of parasiticides, Adaptil® (formerly D.A.P.) and Feliway® pheromone behavior aids and Senilife® neuroprotection for aging pets.  Ceva Biomune's key poultry products include CEVAC® Transmune IBD, Vectormune® FP and Vectormune® HVT.   Senilife is a registered trademark of Innovet Italia S.r.l.  All other trademarks are the property of Ceva Santé Animale S.A. and its affiliates. Its headquarters is in Libourne, France. Visit www.ceva.com. Ceva Biomune Campus and the North America Zone headquarters are both located in Lenexa, Kansas.  Visit www.ceva.us.

      About Ceva Santé Animale S.A: Ceva's parent company is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.

      Do not use Vectra® 3D on cats.

      Media Alert: Press Conference
      Saturday, August 6, 2016 9:00 a.m.
      Press Room 210A
      AVMA Convention
      Henry B. Gonzalez Convention Center

      Contacts: Lea-Ann Germinder, APR
      [email protected]
      @lgerminder
      Caitlyn O'Hare
      [email protected]
      212-367-2170
      (917) 334 -8682
      #FightHeartworm

      Photo - http://photos.prnewswire.com/prnh/20160805/395933-INFO
      Logo - http://photos.prnewswire.com/prnh/20160805/395934LOGO

      SOURCE Ceva Animal Health

      Modal title

      Also from this source

      Ceva Animal Health appoints Sébastien Huron as Deputy Chief Executive Officer

      Ceva Animal Health appoints Sébastien Huron as Deputy Chief Executive Officer

      Ceva Animal Health, the world's fifth largest animal health company, majority-owned by its management team, today announces the appointment of...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Animal Welfare

      Animal Welfare

      Animals & Pets

      Animals & Pets

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.